Loading insider details...
Beta
Latest Form 4 (Sep 23, 2026): Exercise/Conversion of 2,223 GILD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2026 | GILEAD SCIENCES, INC. (GILD) | Exercise/Conversion | 2,223 | n/a |
| Mar 12, 2026 | GILEAD SCIENCES, INC. (GILD) | Grant/Award | 2,355 | n/a |
| Sep 23, 2025 | GILEAD SCIENCES, INC. (GILD) | Grant/Award | 8,890 | n/a |
| May 20, 2025 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax Withholding | 996 | $59.0K |
| Mar 20, 2025 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale | 1,295 | $92.6K |
| Mar 18, 2025 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax Withholding | 823 | $57.1K |
| Feb 25, 2025 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale | 1,344 | $91.9K |
| Aug 15, 2024 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale | 714 | $64.3K |
| May 20, 2024 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Tax Withholding | 993 | $76.4K |
| Apr 12, 2024 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Sale | 2,286 | $205.7K |